An email has been sent to your address with instructions for changing your password.
There is no user registered with this email.
Sign Up
To create a free account, please fill out the form below.
Thank you for signing up!
A confirmation email has been sent to your email address. Please check your email and follow the instructions in the message to complete the registration process. If you do not receive the email, please check your spam folder or contact us for assistance.
Welcome to our platform!
Oops!
Something went wrong while trying to create your new account. Please try again and if the problem persist, Email Us to receive support.
Taysha Gene Therapies to Participate in Upcoming November Investor Healthcare Conferences
Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary
Taysha Gene Therapies (Nasdaq: TSHA) has announced its participation in three significant healthcare conferences: the Stifel 2021 Virtual Healthcare Conference on November 15, 2021, the Jefferies London Healthcare Conference on November 17, 2021, and the 4th Annual Evercore ISI HealthCONx Virtual Conference on November 30, 2021. The company focuses on developing AAV-based gene therapies for monogenic CNS diseases. Key participants include CEO RA Session II, Chief Medical Officer Dr. Suyash Prasad, and CFO Kamran Alam.
Positive
None.
Negative
None.
Stifel 2021 Virtual Healthcare Conference on November 15, 2021 at 11:20 am ET
Jefferies London Healthcare ConferenceNovember 17, 2021 at 12:20 pm GMT
4th Annual Evercore ISI HealthCONx Virtual Conference on November 30, 2021 at 4:20 pm ET
DALLAS--(BUSINESS WIRE)--
Taysha Gene Therapies, Inc. (Nasdaq: TSHA), a patient-centric, pivotal-stage gene therapy company focused on developing and commercializing AAV-based gene therapies for the treatment of monogenic diseases of the central nervous system (CNS) in both rare and large patient populations, today announced its participation in the Stifel 2021 Virtual Healthcare Conference, Jefferies London Healthcare Conference, and the 4th Annual Evercore ISI HealthCONx Virtual Conference.
Conference Details:
Event:
Stifel 2021 Virtual Healthcare Conference
Date:
November 15, 2021
Time:
11:20 am ET
Format:
Fireside Chat
Participants:
RA Session II, President, Founder and Chief Executive Officer
Dr. Suyash Prasad, Chief Medical Officer and Head of R&D
Kamran Alam, Chief Financial Officer
Dr. Kimberly Lee, SVP, Corporate Communications and Investor Relations
Event:
Jefferies London Healthcare Conference
Date:
November 17, 2021
Time:
12:20 pm GMT
Format:
Fireside Chat
Participant:
RA Session II, President, Founder and Chief Executive Officer
Dr. Suyash Prasad, Chief Medical Officer and Head of R&D
Kamran Alam, Chief Financial Officer
Dr. Kimberly Lee, SVP, Corporate Communications and Investor Relations
RA Session II, President, Founder and Chief Executive Officer
Dr. Suyash Prasad, Chief Medical Officer and Head of R&D
Kamran Alam, Chief Financial Officer
Dr. Kimberly Lee, SVP, Corporate Communications and Investor Relations
About Taysha Gene Therapies
Taysha Gene Therapies (Nasdaq: TSHA) is on a mission to eradicate monogenic CNS disease. With a singular focus on developing curative medicines, we aim to rapidly translate our treatments from bench to bedside. We have combined our team’s proven experience in gene therapy drug development and commercialization with the world-class UT Southwestern Gene Therapy Program to build an extensive, AAV gene therapy pipeline focused on both rare and large-market indications. Together, we leverage our fully integrated platform—an engine for potential new cures—with a goal of dramatically improving patients’ lives. More information is available at www.tayshagtx.com.
What conferences is Taysha Gene Therapies participating in November 2021?
Taysha Gene Therapies will participate in the Stifel 2021 Virtual Healthcare Conference on November 15, the Jefferies London Healthcare Conference on November 17, and the 4th Annual Evercore ISI HealthCONx Virtual Conference on November 30.
When will Taysha Gene Therapies be speaking at the Stifel 2021 Virtual Healthcare Conference?
Taysha Gene Therapies will be speaking at the Stifel 2021 Virtual Healthcare Conference on November 15, 2021, at 11:20 am ET.
Who are the key participants from Taysha Gene Therapies at the November 2021 conferences?
Key participants include CEO RA Session II, Chief Medical Officer Dr. Suyash Prasad, and CFO Kamran Alam.
What is the focus of Taysha Gene Therapies?
Taysha Gene Therapies focuses on developing and commercializing AAV-based gene therapies for treating monogenic diseases of the central nervous system.
What date is the 4th Annual Evercore ISI HealthCONx Virtual Conference?
The 4th Annual Evercore ISI HealthCONx Virtual Conference is scheduled for November 30, 2021.
